Skip to main content
Premium Trial:

Request an Annual Quote

Verily Life Sciences Coronavirus Test Gets FDA Emergency Use Authorization

NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for Verily Life Science's molecular SARS-CoV-2 test.

The Verily COVID-19 RT-PCR Test is designed to detect the ORF1ab, N, and S genes of SARS-CoV-2 in upper respiratory specimens and can be used with pooled samples containing up to 12 individual specimens collected by healthcare providers.

The test is a modified version of Thermo Fisher Scientific's authorized TaqPath COVID-19 Combo Kit that uses a matrix 2D-pooling strategy for which samples are pooled in a 96-well plate and includes procedural modifications that compensate for sample dilution during the pooled testing, according to the FDA.

RNA extraction is performed using Thermo Fisher's MagMax Viral/Pathogen Nucleic Acid Isolation Kit and KingFisher Flex Magnetic Particle Processor, and the test runs on Thermo Fisher's Applied Biosystems 7500 Dx Fast Real-Time PCR System or Applied Biosystems QuantStudio 5 Real-Time PCR System.

The test may be performed only by South San Francisco-based Verily, a sister company to Google. Both firms are owned parent company Alphabet.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.